Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors

SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acqu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Protein science 2001-10, Vol.10 (10), p.2008-2016
Hauptverfasser: Qiu, Xiayang, Janson, Cheryl A., Smith, Ward W., Green, Susan M., McDevitt, Patrick, Johanson, Kyung, Carter, Paul, Hibbs, Martin, Lewis, Ceri, Chalker, Alison, Fosberry, Andrew, Lalonde, Judith, Berge, John, Brown, Pamela, Houge‐Frydrych, Catherine S.V., Jarvest, Richard L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2016
container_issue 10
container_start_page 2008
container_title Protein science
container_volume 10
creator Qiu, Xiayang
Janson, Cheryl A.
Smith, Ward W.
Green, Susan M.
McDevitt, Patrick
Johanson, Kyung
Carter, Paul
Hibbs, Martin
Lewis, Ceri
Chalker, Alison
Fosberry, Andrew
Lalonde, Judith
Berge, John
Brown, Pamela
Houge‐Frydrych, Catherine S.V.
Jarvest, Richard L.
description SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acquired infections. The full‐length enzyme yielded crystals that diffracted to 2.8 Å resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Å. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.
doi_str_mv 10.1110/ps.18001
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2374228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71208650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4088-3ec788ee6c1f6d1d08297c1ea6c9c81ad0e7785a6178f7ba3c0913346ad59bdd3</originalsourceid><addsrcrecordid>eNp1kc2KFDEQx4Mo7rgKPoHkJF56t6q7J52-CMuwfsDiyqrgLWTSaTuS6bSptGtfxEfwGX0Ss87gx8FTQdWPXxX1Z-whwgkiwulEJygB8BZbYS3aQrbi_W22glZgISshj9g9oo8AUGNZ3WVHiGvRQFuu2NdNXChpzynF2aQ5Wh56_ibpaVh8MMGYmbjO7VzSEgMt_se37-nq1RmnZUyDTZosdyM3YTd5-4VfuzRwzY3XRDeqKSQ7Jq7HjtNkjeudyfjgti6FSPfZnV57sg8O9Zi9e3b-dvOiuLh8_nJzdlGYGqQsKmsaKa0VBnvRYQeybBuDVgvTGom6A9s0cq0FNrJvtroy0GJV1UJ363bbddUxe7r3TvN2ZzuTT4raqym6nY6LCtqpfyejG9SH8FmVVVOXpcyCxwdBDJ9mS0ntHBnrvR5tmEk1WIIUa8jgkz1o8rMo2v73EgR1E5aaSP0KK6OP_j7qD3hIJwOne-Daebv8V6ReX10ilACy-gny2KOE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71208650</pqid></control><display><type>article</type><title>Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Qiu, Xiayang ; Janson, Cheryl A. ; Smith, Ward W. ; Green, Susan M. ; McDevitt, Patrick ; Johanson, Kyung ; Carter, Paul ; Hibbs, Martin ; Lewis, Ceri ; Chalker, Alison ; Fosberry, Andrew ; Lalonde, Judith ; Berge, John ; Brown, Pamela ; Houge‐Frydrych, Catherine S.V. ; Jarvest, Richard L.</creator><creatorcontrib>Qiu, Xiayang ; Janson, Cheryl A. ; Smith, Ward W. ; Green, Susan M. ; McDevitt, Patrick ; Johanson, Kyung ; Carter, Paul ; Hibbs, Martin ; Lewis, Ceri ; Chalker, Alison ; Fosberry, Andrew ; Lalonde, Judith ; Berge, John ; Brown, Pamela ; Houge‐Frydrych, Catherine S.V. ; Jarvest, Richard L.</creatorcontrib><description>SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acquired infections. The full‐length enzyme yielded crystals that diffracted to 2.8 Å resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Å. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.</description><identifier>ISSN: 0961-8368</identifier><identifier>EISSN: 1469-896X</identifier><identifier>DOI: 10.1110/ps.18001</identifier><identifier>PMID: 11567092</identifier><language>eng</language><publisher>Bristol: Cold Spring Harbor Laboratory Press</publisher><subject>Amino Acid Sequence ; Bridged Bicyclo Compounds, Heterocyclic - chemistry ; Bridged Bicyclo Compounds, Heterocyclic - pharmacology ; bsTyrRS, Bacillus stearothermophilus TyrRS ; bsTyrRStr, C‐terminal domain truncated bsTyrRS ; Crystallization ; Crystallography, X-Ray ; Dipeptides - chemistry ; Dipeptides - pharmacology ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Furans - chemistry ; Furans - pharmacology ; Models, Molecular ; Molecular Sequence Data ; Piperidines - chemistry ; Piperidines - pharmacology ; Protein Conformation ; Sequence Homology, Amino Acid ; Staphylococcus aureus ; Staphylococcus aureus - enzymology ; structure‐based drug design ; truncation ; Tyrosine-tRNA Ligase - antagonists &amp; inhibitors ; Tyrosine-tRNA Ligase - chemistry ; Tyrosyl‐tRNA synthase ; TyrRS, tyrosyl‐tRNA synthetase ; YRS, Staphylococcus aureus tyrosyl‐tRNA synthetase ; YRStr, C‐terminal domain truncated YRS</subject><ispartof>Protein science, 2001-10, Vol.10 (10), p.2008-2016</ispartof><rights>Copyright © 2001 The Protein Society</rights><rights>Copyright © Copyright 2001 The Protein Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4088-3ec788ee6c1f6d1d08297c1ea6c9c81ad0e7785a6178f7ba3c0913346ad59bdd3</citedby><cites>FETCH-LOGICAL-c4088-3ec788ee6c1f6d1d08297c1ea6c9c81ad0e7785a6178f7ba3c0913346ad59bdd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374228/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374228/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,1427,27903,27904,45553,45554,46388,46812,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11567092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qiu, Xiayang</creatorcontrib><creatorcontrib>Janson, Cheryl A.</creatorcontrib><creatorcontrib>Smith, Ward W.</creatorcontrib><creatorcontrib>Green, Susan M.</creatorcontrib><creatorcontrib>McDevitt, Patrick</creatorcontrib><creatorcontrib>Johanson, Kyung</creatorcontrib><creatorcontrib>Carter, Paul</creatorcontrib><creatorcontrib>Hibbs, Martin</creatorcontrib><creatorcontrib>Lewis, Ceri</creatorcontrib><creatorcontrib>Chalker, Alison</creatorcontrib><creatorcontrib>Fosberry, Andrew</creatorcontrib><creatorcontrib>Lalonde, Judith</creatorcontrib><creatorcontrib>Berge, John</creatorcontrib><creatorcontrib>Brown, Pamela</creatorcontrib><creatorcontrib>Houge‐Frydrych, Catherine S.V.</creatorcontrib><creatorcontrib>Jarvest, Richard L.</creatorcontrib><title>Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors</title><title>Protein science</title><addtitle>Protein Sci</addtitle><description>SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acquired infections. The full‐length enzyme yielded crystals that diffracted to 2.8 Å resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Å. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.</description><subject>Amino Acid Sequence</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - chemistry</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - pharmacology</subject><subject>bsTyrRS, Bacillus stearothermophilus TyrRS</subject><subject>bsTyrRStr, C‐terminal domain truncated bsTyrRS</subject><subject>Crystallization</subject><subject>Crystallography, X-Ray</subject><subject>Dipeptides - chemistry</subject><subject>Dipeptides - pharmacology</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Furans - chemistry</subject><subject>Furans - pharmacology</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Piperidines - chemistry</subject><subject>Piperidines - pharmacology</subject><subject>Protein Conformation</subject><subject>Sequence Homology, Amino Acid</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - enzymology</subject><subject>structure‐based drug design</subject><subject>truncation</subject><subject>Tyrosine-tRNA Ligase - antagonists &amp; inhibitors</subject><subject>Tyrosine-tRNA Ligase - chemistry</subject><subject>Tyrosyl‐tRNA synthase</subject><subject>TyrRS, tyrosyl‐tRNA synthetase</subject><subject>YRS, Staphylococcus aureus tyrosyl‐tRNA synthetase</subject><subject>YRStr, C‐terminal domain truncated YRS</subject><issn>0961-8368</issn><issn>1469-896X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc2KFDEQx4Mo7rgKPoHkJF56t6q7J52-CMuwfsDiyqrgLWTSaTuS6bSptGtfxEfwGX0Ss87gx8FTQdWPXxX1Z-whwgkiwulEJygB8BZbYS3aQrbi_W22glZgISshj9g9oo8AUGNZ3WVHiGvRQFuu2NdNXChpzynF2aQ5Wh56_ibpaVh8MMGYmbjO7VzSEgMt_se37-nq1RmnZUyDTZosdyM3YTd5-4VfuzRwzY3XRDeqKSQ7Jq7HjtNkjeudyfjgti6FSPfZnV57sg8O9Zi9e3b-dvOiuLh8_nJzdlGYGqQsKmsaKa0VBnvRYQeybBuDVgvTGom6A9s0cq0FNrJvtroy0GJV1UJ363bbddUxe7r3TvN2ZzuTT4raqym6nY6LCtqpfyejG9SH8FmVVVOXpcyCxwdBDJ9mS0ntHBnrvR5tmEk1WIIUa8jgkz1o8rMo2v73EgR1E5aaSP0KK6OP_j7qD3hIJwOne-Daebv8V6ReX10ilACy-gny2KOE</recordid><startdate>200110</startdate><enddate>200110</enddate><creator>Qiu, Xiayang</creator><creator>Janson, Cheryl A.</creator><creator>Smith, Ward W.</creator><creator>Green, Susan M.</creator><creator>McDevitt, Patrick</creator><creator>Johanson, Kyung</creator><creator>Carter, Paul</creator><creator>Hibbs, Martin</creator><creator>Lewis, Ceri</creator><creator>Chalker, Alison</creator><creator>Fosberry, Andrew</creator><creator>Lalonde, Judith</creator><creator>Berge, John</creator><creator>Brown, Pamela</creator><creator>Houge‐Frydrych, Catherine S.V.</creator><creator>Jarvest, Richard L.</creator><general>Cold Spring Harbor Laboratory Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200110</creationdate><title>Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors</title><author>Qiu, Xiayang ; Janson, Cheryl A. ; Smith, Ward W. ; Green, Susan M. ; McDevitt, Patrick ; Johanson, Kyung ; Carter, Paul ; Hibbs, Martin ; Lewis, Ceri ; Chalker, Alison ; Fosberry, Andrew ; Lalonde, Judith ; Berge, John ; Brown, Pamela ; Houge‐Frydrych, Catherine S.V. ; Jarvest, Richard L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4088-3ec788ee6c1f6d1d08297c1ea6c9c81ad0e7785a6178f7ba3c0913346ad59bdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amino Acid Sequence</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - chemistry</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - pharmacology</topic><topic>bsTyrRS, Bacillus stearothermophilus TyrRS</topic><topic>bsTyrRStr, C‐terminal domain truncated bsTyrRS</topic><topic>Crystallization</topic><topic>Crystallography, X-Ray</topic><topic>Dipeptides - chemistry</topic><topic>Dipeptides - pharmacology</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Furans - chemistry</topic><topic>Furans - pharmacology</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Piperidines - chemistry</topic><topic>Piperidines - pharmacology</topic><topic>Protein Conformation</topic><topic>Sequence Homology, Amino Acid</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - enzymology</topic><topic>structure‐based drug design</topic><topic>truncation</topic><topic>Tyrosine-tRNA Ligase - antagonists &amp; inhibitors</topic><topic>Tyrosine-tRNA Ligase - chemistry</topic><topic>Tyrosyl‐tRNA synthase</topic><topic>TyrRS, tyrosyl‐tRNA synthetase</topic><topic>YRS, Staphylococcus aureus tyrosyl‐tRNA synthetase</topic><topic>YRStr, C‐terminal domain truncated YRS</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qiu, Xiayang</creatorcontrib><creatorcontrib>Janson, Cheryl A.</creatorcontrib><creatorcontrib>Smith, Ward W.</creatorcontrib><creatorcontrib>Green, Susan M.</creatorcontrib><creatorcontrib>McDevitt, Patrick</creatorcontrib><creatorcontrib>Johanson, Kyung</creatorcontrib><creatorcontrib>Carter, Paul</creatorcontrib><creatorcontrib>Hibbs, Martin</creatorcontrib><creatorcontrib>Lewis, Ceri</creatorcontrib><creatorcontrib>Chalker, Alison</creatorcontrib><creatorcontrib>Fosberry, Andrew</creatorcontrib><creatorcontrib>Lalonde, Judith</creatorcontrib><creatorcontrib>Berge, John</creatorcontrib><creatorcontrib>Brown, Pamela</creatorcontrib><creatorcontrib>Houge‐Frydrych, Catherine S.V.</creatorcontrib><creatorcontrib>Jarvest, Richard L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Protein science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qiu, Xiayang</au><au>Janson, Cheryl A.</au><au>Smith, Ward W.</au><au>Green, Susan M.</au><au>McDevitt, Patrick</au><au>Johanson, Kyung</au><au>Carter, Paul</au><au>Hibbs, Martin</au><au>Lewis, Ceri</au><au>Chalker, Alison</au><au>Fosberry, Andrew</au><au>Lalonde, Judith</au><au>Berge, John</au><au>Brown, Pamela</au><au>Houge‐Frydrych, Catherine S.V.</au><au>Jarvest, Richard L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors</atitle><jtitle>Protein science</jtitle><addtitle>Protein Sci</addtitle><date>2001-10</date><risdate>2001</risdate><volume>10</volume><issue>10</issue><spage>2008</spage><epage>2016</epage><pages>2008-2016</pages><issn>0961-8368</issn><eissn>1469-896X</eissn><abstract>SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acquired infections. The full‐length enzyme yielded crystals that diffracted to 2.8 Å resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Å. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.</abstract><cop>Bristol</cop><pub>Cold Spring Harbor Laboratory Press</pub><pmid>11567092</pmid><doi>10.1110/ps.18001</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0961-8368
ispartof Protein science, 2001-10, Vol.10 (10), p.2008-2016
issn 0961-8368
1469-896X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2374228
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Free Content; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Amino Acid Sequence
Bridged Bicyclo Compounds, Heterocyclic - chemistry
Bridged Bicyclo Compounds, Heterocyclic - pharmacology
bsTyrRS, Bacillus stearothermophilus TyrRS
bsTyrRStr, C‐terminal domain truncated bsTyrRS
Crystallization
Crystallography, X-Ray
Dipeptides - chemistry
Dipeptides - pharmacology
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
Furans - chemistry
Furans - pharmacology
Models, Molecular
Molecular Sequence Data
Piperidines - chemistry
Piperidines - pharmacology
Protein Conformation
Sequence Homology, Amino Acid
Staphylococcus aureus
Staphylococcus aureus - enzymology
structure‐based drug design
truncation
Tyrosine-tRNA Ligase - antagonists & inhibitors
Tyrosine-tRNA Ligase - chemistry
Tyrosyl‐tRNA synthase
TyrRS, tyrosyl‐tRNA synthetase
YRS, Staphylococcus aureus tyrosyl‐tRNA synthetase
YRStr, C‐terminal domain truncated YRS
title Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A22%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Crystal%20structure%20of%20Staphylococcus%20aureus%20tyrosyl%E2%80%90tRNA%20synthetase%20in%20complex%20with%20a%20class%20of%20potent%20and%20specific%20inhibitors&rft.jtitle=Protein%20science&rft.au=Qiu,%20Xiayang&rft.date=2001-10&rft.volume=10&rft.issue=10&rft.spage=2008&rft.epage=2016&rft.pages=2008-2016&rft.issn=0961-8368&rft.eissn=1469-896X&rft_id=info:doi/10.1110/ps.18001&rft_dat=%3Cproquest_pubme%3E71208650%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71208650&rft_id=info:pmid/11567092&rfr_iscdi=true